Long-term prognosis of medullary thyroid carcinoma

Clinical Endocrinology

Volumn 69, Issue 3, 2008, Pages 497-505

  Rendl, G ^a   Manzl, M ^a   Hitzl, W ^a   Sungler, P ^a   Pirich, C ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CALCITONIN; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OCTREOTIDE; TECHNETIUM 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HUMAN; LYMPH NODE METASTASIS; MALE; MORTALITY; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; SURVIVAL TIME; THYROID MEDULLARY CARCINOMA; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; CARCINOMA, MEDULLARY; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 49649088417     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03229.x     Document Type: Article

References (30)

1. Kebebew, E., Ituarte, P.H., Siperstein, A.E., Duh, Q.Y. Clark, O.H. (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer, 88, 1139 1148.
2. Lairmore, T.C. Wells, S.A. Jr (1991) Medullary carcinoma of the thyroid: current diagnosis and management. Seminars in Surgical Oncology, 7, 92 99.
3. Leboulleux, S., Baudin, E., Travagli, J.P. Schlumberger, M. (2004) Medullary thyroid carcinoma. Clinical Endocrinology, 61, 299 310.
4. de Groot, J.W., Kema, I.P., Breukelman, H., van der Veer, E., Wiggers, T., Plukker, J.T., Wolffenbuttel, B.H.R. Links, T.P. (2006) Biochemical markers in the follow-up of medullary thyroid cancer. Thyroid, 16, 1163 1170.
5. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. European Journal of Nuclear Medicine, 28, 64 71.
6. Elisei, R., Bottici, V., Luchetti, F., di Coscio, G., Romei, C., Grasso, L., Miccoli, P., Iacconi, P., Basolo, F., Pinchera, A. Pacini, F. (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10 864 patients with nodular thyroid disorders. Journal of Clinical Endocrinology and Metabolism, 89, 163 168.
7. Vitale, G., Caraglia, M., Ciccarelli, A., Lupoli, G., Abbruzzese, A., Tagliaferri, P. Lupoli, G. (2001) Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer, 91, 1797 1808.
8. Modigliani, E., Cohen, R., Campos, J.M., Conte-Devolx, B., Maes, B., Boneu, A., Schlumberger, M., Bigorgne, J.-C., Dumontier, P., Leclerc, L., Corcuff, B. Guilhem, I. (1998) Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clinical Endocrinology, 48, 265 273.
9. van Heerden, J.A., Grant, C.S., Gharib, H., Hay, I.D. Ilstrup, D.M. (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Annals of Surgery, 212, 395 400.
10. Girelli, M.E., Nacamulli, D., Pelizzo, M.R., De Vido, D., Mian, C., Piccolo, M. Busnardo, B. (1998) Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. Thyroid, 8, 517 523.
11. Clark, J.R., Fridman, T.R., Odell, M.J., Brierley, J., Walfish, P.G. Freeman, J.L. (2005) Prognostic variables and calcitonin in medullary thyroid cancer. The Laryngoscope, 115, 1445 1450.
12. Bergholm, U., Bergstroem, R. Ekbom, A. (1997) Long term follow-up of patients with medullary carcinoma of the thyroid. Cancer, 79, 132 138.
13. Gimm, O., Sutter, T. Dralle, H. (2001) Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. Journal of Cancer Research and Clinical Oncology, 127, 156 165.
14. Fink, M., Weinhusel, A., Niederle, B. Haas, O.A. (1996) Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. 'Study Group Multiple Endocrine Neoplasia Austria (SMENA)'. International Journal of Cancer, 69, 312 316.
15. Weinhausel, A., Kaserer, K., Vierhapper, H., Niederle, B. Haas, O.A. (2002) Multiple endocrine neoplasia type 1 (MEN 1) in Austria. Wiener Klinische Wochenschrift, 114, 252 257.
16. Bieglmayer, C., Vierhapper, H., Dudczak, R. Niederle, B. (2007) Measurement of calcitonin by immunoassay analyzers. Clinical Chemistry and Laboratory Medicine, 45, 662 666.
17. 18F-DOPA PET/CT and neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging, 33, 509 513.
18. Kebebew, E., Kikuchi, S., Duh, Q.Y. Clark, O.H. (2000) Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Archives of Surgery, 135, 895 901.
19. Sungler, P. Niederle, B. (2006) Surgical treatment of thyroid carcinoma. European Surgery, 38, 41 44.
20. de Groot, J.W., Plukker, J., Wolffenbuttel, B., Wiggers, T., Sluiter, W.J. Links, T.P. (2006) Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clinical Endocrinology, 65, 729 736.
21. Hyer, S.L., Vini, L., A'Hern, R. Harmer, C. (2000) Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. European Journal of Surgical Oncology, 26, 686 690.
22. Saad, M.F., Ordonez, N.G., Rashid, R.K., Guido, J.J., Hill, C.S. Jr, Hickey R.C. Samaan, N.A. (1984) Medullary carcinoma of the thyroid. A study of the clinical prognostic factors in 161 patients. Medicine (Baltimore), 63, 319 342.
23. Raue, F., Kotzerke, J., Reinwein, D., Schröder, S., Röher, H.D., Deckart, H., Höfer, R., Ritter, M., Seif, F., Buhr, H., Beyer, J., Schober, O., Becker, W., Neumann, H., Calvi, J., Winter, J., Vogt, H. the German Medullary Thyroid Carcinoma Study Group (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. The Clinical Investigator, 71, 7 12.
24. Scollo, C., Baudin, E., Travagli, J.P., Caillou, B., Bellon, N., Leboulleux, S. Schlumberger, M. (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 2070 2075.
25. Giraudet, A.L., Vanel, D., Leboulleux, S., Aupérin, A., Dromain, C., Chami, L., Tovo, N.N., Lumbroso, J., Lassau, N., Bonniaud, G., Hartl, D., Travagli, J.-P., Baudin, E. Schlumberger, M. (2007) Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. Journal of Clinical Endocrinology and Metabolism, 92, 4185 4190.
26. 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study. European Journal of Surgical Oncology, 34, 581 586.
27. Oudoux, A., Salaun, P.Y., Bournaud, C., Campion, L., Ansquer, C., Rousseau, C., Bardet, S., Borson-Chazot, F., Vuillez, J.-P., Murat, A., Mirallié, E., Barbet, J., Goldenberg, D.M., Chatal, J.-F. Kraeber-Bodéré, F. (2007) Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy. Journal of Clinical Endocrinology and Metabolism, 92, 4590 4597.
28. Ball, D.W. (2007) Medullary thyroid cancer: monitoring and therapy. Endocrinology and Metabolism Clinics of North America, 36, 823 837.
29. Chen, H., Roberts, J.R., Ball, D.W., Eisele, D.W., Baylin, S.B., Udelsman, R. Bulkley, G.B. (1998) Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Annals of Surgery, 227, 887 895.
30. Franc, S., Niccoli-Sire, P., Cohen, R., Bardet, S., Maes, B., Murat, A., Krivitzky, A., Modigliani, E. The French Medullary Study Group (GETC 2001) Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Clinical Endocrinology, 55, 403 409.